Skip to content

Drug interactions

Dapagliflozin-metformin + Lanreotide

Severity: Moderate

Dapagliflozin-metformin and Lanreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lanreotide suppresses insulin, glucagon and incretin secretion, which can cause either hyperglycemia or hypoglycemia in diabetic patients. Glucose-lowering needs may change after starting it.

What this interaction means in plain words

Dapagliflozin-metformin and Lanreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dapagliflozin-metformin belongs to Endocrine; Lanreotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Somatostatin analogue inhibition of insulin and counter-regulatory hormone secretion alters glycemic control.

What to do

Monitor blood glucose when starting or adjusting lanreotide and modify the antidiabetic regimen as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapagliflozin-metformin and Lanreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dapagliflozin-metformin with Lanreotide?

MediHelp rates the interaction as moderate. Dapagliflozin-metformin and Lanreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lanreotide suppresses insulin, glucagon and incretin secretion, which can cause either hyperglycemia or hypoglycemia in diabetic patients. Glucose-lowering needs may change after starting it.

How serious is the interaction between Dapagliflozin-metformin and Lanreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or adjusting lanreotide and modify the antidiabetic regimen as needed.

What other medicines interact with Dapagliflozin-metformin?

MediHelp also lists interactions of Dapagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Dapagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in